JP2007332126A - ヒトおよび愛玩動物のための抗白癬入浴剤 - Google Patents
ヒトおよび愛玩動物のための抗白癬入浴剤 Download PDFInfo
- Publication number
- JP2007332126A JP2007332126A JP2006193389A JP2006193389A JP2007332126A JP 2007332126 A JP2007332126 A JP 2007332126A JP 2006193389 A JP2006193389 A JP 2006193389A JP 2006193389 A JP2006193389 A JP 2006193389A JP 2007332126 A JP2007332126 A JP 2007332126A
- Authority
- JP
- Japan
- Prior art keywords
- ringworm
- essential oil
- oil
- skin
- hair
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 208000002474 Tinea Diseases 0.000 title claims abstract description 36
- 241001465754 Metazoa Species 0.000 title claims abstract description 14
- 239000013040 bath agent Substances 0.000 title claims abstract description 7
- 239000000341 volatile oil Substances 0.000 claims abstract description 59
- 241000893966 Trichophyton verrucosum Species 0.000 claims abstract description 32
- 229930004725 sesquiterpene Natural products 0.000 claims abstract description 31
- 150000004354 sesquiterpene derivatives Chemical class 0.000 claims abstract description 28
- 241000196324 Embryophyta Species 0.000 claims abstract description 14
- 230000000694 effects Effects 0.000 claims abstract description 13
- CRDAMVZIKSXKFV-FBXUGWQNSA-N (2-cis,6-cis)-farnesol Chemical compound CC(C)=CCC\C(C)=C/CC\C(C)=C/CO CRDAMVZIKSXKFV-FBXUGWQNSA-N 0.000 claims abstract description 12
- 239000000260 (2E,6E)-3,7,11-trimethyldodeca-2,6,10-trien-1-ol Substances 0.000 claims abstract description 12
- 229930002886 farnesol Natural products 0.000 claims abstract description 12
- 229940043259 farnesol Drugs 0.000 claims abstract description 12
- CRDAMVZIKSXKFV-UHFFFAOYSA-N trans-Farnesol Natural products CC(C)=CCCC(C)=CCCC(C)=CCO CRDAMVZIKSXKFV-UHFFFAOYSA-N 0.000 claims abstract description 12
- 239000010671 sandalwood oil Substances 0.000 claims abstract description 6
- 230000002265 prevention Effects 0.000 claims abstract 3
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims description 18
- 239000003921 oil Substances 0.000 claims description 9
- 238000003287 bathing Methods 0.000 claims description 8
- 239000001306 (7E,9E,11E,13E)-pentadeca-7,9,11,13-tetraen-1-ol Substances 0.000 claims description 5
- 241000233866 Fungi Species 0.000 claims description 5
- 239000003795 chemical substances by application Substances 0.000 claims description 5
- -1 visabolol Chemical compound 0.000 claims description 5
- SVURIXNDRWRAFU-OGMFBOKVSA-N cedrol Chemical compound C1[C@]23[C@H](C)CC[C@H]3C(C)(C)[C@@H]1[C@@](O)(C)CC2 SVURIXNDRWRAFU-OGMFBOKVSA-N 0.000 claims description 3
- 229940026455 cedrol Drugs 0.000 claims description 3
- PCROEXHGMUJCDB-UHFFFAOYSA-N cedrol Natural products CC1CCC2C(C)(C)C3CC(C)(O)CC12C3 PCROEXHGMUJCDB-UHFFFAOYSA-N 0.000 claims description 3
- SVURIXNDRWRAFU-UHFFFAOYSA-N juniperanol Natural products C1C23C(C)CCC3C(C)(C)C1C(O)(C)CC2 SVURIXNDRWRAFU-UHFFFAOYSA-N 0.000 claims description 3
- FQTLCLSUCSAZDY-UHFFFAOYSA-N (+) E(S) nerolidol Natural products CC(C)=CCCC(C)=CCCC(C)(O)C=C FQTLCLSUCSAZDY-UHFFFAOYSA-N 0.000 claims description 2
- 240000007436 Cananga odorata Species 0.000 claims description 2
- LLKXNMNOHBQSJW-UHFFFAOYSA-N Elemol Natural products CCC(=C)C1CC(C=CC1(C)C)C(C)(C)O LLKXNMNOHBQSJW-UHFFFAOYSA-N 0.000 claims description 2
- FQTLCLSUCSAZDY-ATGUSINASA-N Nerolidol Chemical compound CC(C)=CCC\C(C)=C\CC[C@](C)(O)C=C FQTLCLSUCSAZDY-ATGUSINASA-N 0.000 claims description 2
- GFJIQNADMLPFOW-UHFFFAOYSA-N cis-Elemol Natural products CC(=C)C1CC(C(C)(C)O)CCC1(C)C=C GFJIQNADMLPFOW-UHFFFAOYSA-N 0.000 claims description 2
- GFJIQNADMLPFOW-VNHYZAJKSA-N elemol Chemical compound CC(=C)[C@@H]1C[C@H](C(C)(C)O)CC[C@@]1(C)C=C GFJIQNADMLPFOW-VNHYZAJKSA-N 0.000 claims description 2
- WASNIKZYIWZQIP-AWEZNQCLSA-N nerolidol Natural products CC(=CCCC(=CCC[C@@H](O)C=C)C)C WASNIKZYIWZQIP-AWEZNQCLSA-N 0.000 claims description 2
- 239000010679 vetiver oil Substances 0.000 claims description 2
- 239000010627 cedar oil Substances 0.000 claims 1
- 239000001738 pogostemon cablin oil Substances 0.000 claims 1
- 238000002791 soaking Methods 0.000 claims 1
- 241000282412 Homo Species 0.000 abstract description 10
- 229940121375 antifungal agent Drugs 0.000 abstract description 6
- 239000003429 antifungal agent Substances 0.000 abstract description 6
- 208000015181 infectious disease Diseases 0.000 abstract description 5
- 229920001817 Agar Polymers 0.000 description 8
- 239000008272 agar Substances 0.000 description 8
- 229930003658 monoterpene Natural products 0.000 description 8
- 150000002773 monoterpene derivatives Chemical class 0.000 description 8
- 235000002577 monoterpenes Nutrition 0.000 description 8
- 238000001179 sorption measurement Methods 0.000 description 8
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 6
- XEKOWRVHYACXOJ-UHFFFAOYSA-N Ethyl acetate Chemical compound CCOC(C)=O XEKOWRVHYACXOJ-UHFFFAOYSA-N 0.000 description 6
- CDOSHBSSFJOMGT-UHFFFAOYSA-N linalool Chemical compound CC(C)=CCCC(C)(O)C=C CDOSHBSSFJOMGT-UHFFFAOYSA-N 0.000 description 6
- 239000000243 solution Substances 0.000 description 6
- 241000894006 Bacteria Species 0.000 description 5
- 208000035415 Reinfection Diseases 0.000 description 5
- 241001045770 Trichophyton mentagrophytes Species 0.000 description 5
- 230000000843 anti-fungal effect Effects 0.000 description 5
- 150000003839 salts Chemical class 0.000 description 5
- 235000002639 sodium chloride Nutrition 0.000 description 5
- CSNNHWWHGAXBCP-UHFFFAOYSA-L Magnesium sulfate Chemical compound [Mg+2].[O-][S+2]([O-])([O-])[O-] CSNNHWWHGAXBCP-UHFFFAOYSA-L 0.000 description 4
- 230000000844 anti-bacterial effect Effects 0.000 description 4
- 238000000034 method Methods 0.000 description 4
- 239000001490 (3R)-3,7-dimethylocta-1,6-dien-3-ol Substances 0.000 description 3
- CDOSHBSSFJOMGT-JTQLQIEISA-N (R)-linalool Natural products CC(C)=CCC[C@@](C)(O)C=C CDOSHBSSFJOMGT-JTQLQIEISA-N 0.000 description 3
- PDEQKAVEYSOLJX-UHFFFAOYSA-N Hexahydronerolidol Natural products C1C2C3(C)C2CC1C3(C)CCC=C(CO)C PDEQKAVEYSOLJX-UHFFFAOYSA-N 0.000 description 3
- 241000699666 Mus <mouse, genus> Species 0.000 description 3
- PDEQKAVEYSOLJX-AIEDFZFUSA-N alpha-Santalol Natural products CC(=CCC[C@@]1(C)[C@H]2C[C@@H]3[C@H](C2)[C@]13C)CO PDEQKAVEYSOLJX-AIEDFZFUSA-N 0.000 description 3
- PDEQKAVEYSOLJX-BKKZDLJQSA-N alpha-santalol Chemical compound C1C2[C@]3(C)C2C[C@H]1[C@@]3(C)CC/C=C(CO)/C PDEQKAVEYSOLJX-BKKZDLJQSA-N 0.000 description 3
- 229930007744 linalool Natural products 0.000 description 3
- 239000007788 liquid Substances 0.000 description 3
- 230000036961 partial effect Effects 0.000 description 3
- 239000012449 sabouraud dextrose agar Substances 0.000 description 3
- 241000282465 Canis Species 0.000 description 2
- 102000011782 Keratins Human genes 0.000 description 2
- 108010076876 Keratins Proteins 0.000 description 2
- 241000699670 Mus sp. Species 0.000 description 2
- 208000031888 Mycoses Diseases 0.000 description 2
- PMZURENOXWZQFD-UHFFFAOYSA-L Sodium Sulfate Chemical compound [Na+].[Na+].[O-]S([O-])(=O)=O PMZURENOXWZQFD-UHFFFAOYSA-L 0.000 description 2
- 241000130764 Tinea Species 0.000 description 2
- 230000003110 anti-inflammatory effect Effects 0.000 description 2
- 239000003788 bath preparation Substances 0.000 description 2
- 238000011088 calibration curve Methods 0.000 description 2
- 229940041514 candida albicans extract Drugs 0.000 description 2
- 125000004432 carbon atom Chemical group C* 0.000 description 2
- 238000012258 culturing Methods 0.000 description 2
- 229940079593 drug Drugs 0.000 description 2
- 239000003814 drug Substances 0.000 description 2
- 238000004817 gas chromatography Methods 0.000 description 2
- 230000002458 infectious effect Effects 0.000 description 2
- 229910052943 magnesium sulfate Inorganic materials 0.000 description 2
- 235000019341 magnesium sulphate Nutrition 0.000 description 2
- 239000002504 physiological saline solution Substances 0.000 description 2
- 230000003449 preventive effect Effects 0.000 description 2
- 230000002829 reductive effect Effects 0.000 description 2
- 239000000725 suspension Substances 0.000 description 2
- 238000002560 therapeutic procedure Methods 0.000 description 2
- MGSRCZKZVOBKFT-UHFFFAOYSA-N thymol Chemical compound CC(C)C1=CC=C(C)C=C1O MGSRCZKZVOBKFT-UHFFFAOYSA-N 0.000 description 2
- 239000012138 yeast extract Substances 0.000 description 2
- NPNUFJAVOOONJE-ZIAGYGMSSA-N β-(E)-Caryophyllene Chemical compound C1CC(C)=CCCC(=C)[C@H]2CC(C)(C)[C@@H]21 NPNUFJAVOOONJE-ZIAGYGMSSA-N 0.000 description 2
- COGPRPSWSKLKTF-CBBWQLFWSA-N (-)-cubenol Chemical compound C1CC(C)=C[C@H]2[C@H](C(C)C)CC[C@@H](C)[C@@]21O COGPRPSWSKLKTF-CBBWQLFWSA-N 0.000 description 1
- INIOTLARNNSXAE-UHFFFAOYSA-N 4,8-dimethyl-2-propan-2-ylidene-3,3a,4,5,6,8a-hexahydro-1h-azulen-6-ol Chemical compound CC1CC(O)C=C(C)C2CC(=C(C)C)CC12 INIOTLARNNSXAE-UHFFFAOYSA-N 0.000 description 1
- 241000282472 Canis lupus familiaris Species 0.000 description 1
- 239000004215 Carbon black (E152) Substances 0.000 description 1
- COGPRPSWSKLKTF-UHFFFAOYSA-N Cubenol Natural products C1CC(C)=CC2C(C(C)C)CCC(C)C21O COGPRPSWSKLKTF-UHFFFAOYSA-N 0.000 description 1
- IAZDPXIOMUYVGZ-UHFFFAOYSA-N Dimethylsulphoxide Chemical compound CS(C)=O IAZDPXIOMUYVGZ-UHFFFAOYSA-N 0.000 description 1
- 241001480036 Epidermophyton floccosum Species 0.000 description 1
- 241000282326 Felis catus Species 0.000 description 1
- 206010017533 Fungal infection Diseases 0.000 description 1
- GAIBLDCXCZKKJE-YZJXYJLZSA-N Germacren D Chemical compound CC(C)C/1CC\C(C)=C\CCC(=C)\C=C\1 GAIBLDCXCZKKJE-YZJXYJLZSA-N 0.000 description 1
- MAEHOUIVWGFBMO-UHFFFAOYSA-N Germacren-D Natural products CC(=C1C=CC(CCC=C(CC1)/C)=C)C MAEHOUIVWGFBMO-UHFFFAOYSA-N 0.000 description 1
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 description 1
- UFHFLCQGNIYNRP-UHFFFAOYSA-N Hydrogen Chemical compound [H][H] UFHFLCQGNIYNRP-UHFFFAOYSA-N 0.000 description 1
- 206010061218 Inflammation Diseases 0.000 description 1
- 206010067125 Liver injury Diseases 0.000 description 1
- 241001295810 Microsporidium Species 0.000 description 1
- 208000003251 Pruritus Diseases 0.000 description 1
- 239000012980 RPMI-1640 medium Substances 0.000 description 1
- VYPSYNLAJGMNEJ-UHFFFAOYSA-N Silicium dioxide Chemical compound O=[Si]=O VYPSYNLAJGMNEJ-UHFFFAOYSA-N 0.000 description 1
- 239000005844 Thymol Substances 0.000 description 1
- 241000223229 Trichophyton rubrum Species 0.000 description 1
- 230000036592 analgesia Effects 0.000 description 1
- 238000004458 analytical method Methods 0.000 description 1
- 230000001760 anti-analgesic effect Effects 0.000 description 1
- 230000001580 bacterial effect Effects 0.000 description 1
- OJYKYCDSGQGTRJ-INLOORNJSA-N beta-Santalol Natural products C1C[C@H]2C(=C)[C@](CC\C=C(CO)/C)(C)[C@@H]1C2 OJYKYCDSGQGTRJ-INLOORNJSA-N 0.000 description 1
- NPNUFJAVOOONJE-UHFFFAOYSA-N beta-cariophyllene Natural products C1CC(C)=CCCC(=C)C2CC(C)(C)C21 NPNUFJAVOOONJE-UHFFFAOYSA-N 0.000 description 1
- OJYKYCDSGQGTRJ-GQYWAMEOSA-N beta-santalol Chemical compound C1C[C@H]2C(=C)[C@@](CC/C=C(CO)/C)(C)[C@@H]1C2 OJYKYCDSGQGTRJ-GQYWAMEOSA-N 0.000 description 1
- 230000015572 biosynthetic process Effects 0.000 description 1
- 230000017531 blood circulation Effects 0.000 description 1
- 239000012159 carrier gas Substances 0.000 description 1
- NPNUFJAVOOONJE-UONOGXRCSA-N caryophyllene Natural products C1CC(C)=CCCC(=C)[C@@H]2CC(C)(C)[C@@H]21 NPNUFJAVOOONJE-UONOGXRCSA-N 0.000 description 1
- 239000002537 cosmetic Substances 0.000 description 1
- 239000010779 crude oil Substances 0.000 description 1
- 238000001514 detection method Methods 0.000 description 1
- 238000010790 dilution Methods 0.000 description 1
- 239000012895 dilution Substances 0.000 description 1
- 238000003113 dilution method Methods 0.000 description 1
- 201000010099 disease Diseases 0.000 description 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 1
- 238000002474 experimental method Methods 0.000 description 1
- 239000000284 extract Substances 0.000 description 1
- 210000002683 foot Anatomy 0.000 description 1
- 239000003205 fragrance Substances 0.000 description 1
- 229930014385 germacrens D Natural products 0.000 description 1
- 239000011521 glass Substances 0.000 description 1
- 239000008103 glucose Substances 0.000 description 1
- 230000009036 growth inhibition Effects 0.000 description 1
- 239000001963 growth medium Substances 0.000 description 1
- 238000010438 heat treatment Methods 0.000 description 1
- 239000001307 helium Substances 0.000 description 1
- 229910052734 helium Inorganic materials 0.000 description 1
- SWQJXJOGLNCZEY-UHFFFAOYSA-N helium atom Chemical compound [He] SWQJXJOGLNCZEY-UHFFFAOYSA-N 0.000 description 1
- 231100000234 hepatic damage Toxicity 0.000 description 1
- 229930195733 hydrocarbon Natural products 0.000 description 1
- 239000001257 hydrogen Substances 0.000 description 1
- 229910052739 hydrogen Inorganic materials 0.000 description 1
- 125000002887 hydroxy group Chemical group [H]O* 0.000 description 1
- 238000007654 immersion Methods 0.000 description 1
- 230000004054 inflammatory process Effects 0.000 description 1
- 230000002401 inhibitory effect Effects 0.000 description 1
- 239000002054 inoculum Substances 0.000 description 1
- GAIBLDCXCZKKJE-UHFFFAOYSA-N isogermacrene D Natural products CC(C)C1CCC(C)=CCCC(=C)C=C1 GAIBLDCXCZKKJE-UHFFFAOYSA-N 0.000 description 1
- 230000007803 itching Effects 0.000 description 1
- 238000009630 liquid culture Methods 0.000 description 1
- 230000008818 liver damage Effects 0.000 description 1
- 239000000463 material Substances 0.000 description 1
- 239000002609 medium Substances 0.000 description 1
- HFPZCAJZSCWRBC-UHFFFAOYSA-N p-cymene Chemical compound CC(C)C1=CC=C(C)C=C1 HFPZCAJZSCWRBC-UHFFFAOYSA-N 0.000 description 1
- GGHMUJBZYLPWFD-CUZKYEQNSA-N patchouli alcohol Chemical compound C1C[C@]2(C)[C@@]3(O)CC[C@H](C)[C@@H]2C[C@@H]1C3(C)C GGHMUJBZYLPWFD-CUZKYEQNSA-N 0.000 description 1
- 235000010482 polyoxyethylene sorbitan monooleate Nutrition 0.000 description 1
- 229920000053 polysorbate 80 Polymers 0.000 description 1
- 238000002360 preparation method Methods 0.000 description 1
- 230000001737 promoting effect Effects 0.000 description 1
- GGHMUJBZYLPWFD-UHFFFAOYSA-N rac-patchouli alcohol Natural products C1CC2(C)C3(O)CCC(C)C2CC1C3(C)C GGHMUJBZYLPWFD-UHFFFAOYSA-N 0.000 description 1
- 239000002994 raw material Substances 0.000 description 1
- 230000002040 relaxant effect Effects 0.000 description 1
- 208000017520 skin disease Diseases 0.000 description 1
- 229910052938 sodium sulfate Inorganic materials 0.000 description 1
- 235000011152 sodium sulphate Nutrition 0.000 description 1
- 239000002904 solvent Substances 0.000 description 1
- 239000008223 sterile water Substances 0.000 description 1
- 239000000126 substance Substances 0.000 description 1
- 239000006228 supernatant Substances 0.000 description 1
- 210000004243 sweat Anatomy 0.000 description 1
- 230000008961 swelling Effects 0.000 description 1
- 208000024891 symptom Diseases 0.000 description 1
- 150000003505 terpenes Chemical class 0.000 description 1
- 235000007586 terpenes Nutrition 0.000 description 1
- 229960000790 thymol Drugs 0.000 description 1
- 201000004647 tinea pedis Diseases 0.000 description 1
- 230000000699 topical effect Effects 0.000 description 1
- 238000005406 washing Methods 0.000 description 1
Landscapes
- Cosmetics (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Abstract
【解決手段】ファルネソールなどのセスキテルペン精油成分は抗白癬菌活性が高く、毛髪や皮膚に対して特異的に高い吸着特性を有しているため、それらの成分や、それらを高濃度に含有するサンダルウッド油などの植物精油は、毛髪や皮膚の白癬に対して治療と予防に効果的に利用できる。また白癬菌は容易に再感染を起こすが、とくに浴室は感染の頻度が高い。したがって、本発明の入浴剤を用いることによって、ヒトの頭部白癬または愛玩動物の皮膚白癬に対し、安全で効果が高く、かつ安価で簡便に治療と予防をおこなうことが可能である。
【選択図】なし
Description
本発明で効果的に用いることのできるセスキテルペン精油成分として具体的には、ファルネソール、ネロリドール、ビザボロール、セドロール、エレモール、アルファー・サンタロールなどがあげられる。セスキテルペンとば炭素数が15個から成るテルペン類を指し、本発明におけるセスキテルペン精油成分には、セスキテルペン炭化水素と、それを母核として水酸基が一個またはそれ以上置換したセスキテルペンアルコールが含まれる。炭素数が10個より成るモノテルペン類は、抗真菌活性が弱い上に毛髪や皮膚に対する吸着性が低かった。
本発明で効果的に用いることのできる植物精油として具体的には、サンダルウッド油(アルファー・サンタロールを約50%含む)、シダーウッド・バージニア油(セドロールを約32%含む)、没薬油(リンデステレンを約38%含む)、バチュリー油(パチュロールを42%含む)、イランイラン油(ゲルマクレンDを約20%含む)、ガルバナム油(グアイオールやキュベノールなどのセスキテルペンアルコール類を約12%含む)、ベチバー油(ベチベロールを約50%含む)などがあげられる。括弧内に記載した名称の物質は、いずれもセスキテルペンである。
実施例1.精油成分および植物精油の抗白癬菌活性
実施例2.植物精油を添加した温水による白癬菌の殺菌効果
実施例3.精油成分のヒト頭髪に対する白癬菌の感染予防効果(液体培養法)
実施例4.精油成分のヒト頭髪に対する白癬菌の感染予防効果(寒天プレート法)
実施例7.ヒトの頭髪に対するセスキテルペン精油成分の吸着特性
Claims (4)
- 抗白癬菌活性を有するセスキテルペン精油成分、またはそれらを10%以上含有する植物精油の中から、少なくとも1種類を選んで配合した入浴剤であって、それを溶解した温水にヒトまたは愛玩動物を浸すことによって実施される皮膚および毛髪の白癬の予防または治療のための入浴剤
- 請求項1における愛玩動物が、イヌまたはネコであることを特徴とする入浴剤
- 請求項1および2におけるセスキテルペン精油成分が、ファルネソール、ネロリドール、ビザボロール、セドロール、エレモール、アルファー・サンタロールであって、入浴に際して、それら各成分の濃度が、単独または併せて温水1リットル当たり12.5mg以上になるように配合および使用量を設定したものであることを特徴とする入浴剤
- 請求項1および2における植物精油が、サンダルウッド油、シダーウッド油、パチュリー油、没薬油、ガルバナム油、イランイラン油、ベチバー油であって、入浴に際して、それらの各精油の濃度が、単独または併せて温水1リットル当たり25mg以上になるように配合および使用量を設定したものであることを特徴とする入浴剤
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP2006193389A JP2007332126A (ja) | 2006-06-16 | 2006-06-16 | ヒトおよび愛玩動物のための抗白癬入浴剤 |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP2006193389A JP2007332126A (ja) | 2006-06-16 | 2006-06-16 | ヒトおよび愛玩動物のための抗白癬入浴剤 |
Publications (1)
Publication Number | Publication Date |
---|---|
JP2007332126A true JP2007332126A (ja) | 2007-12-27 |
Family
ID=38931927
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
JP2006193389A Pending JP2007332126A (ja) | 2006-06-16 | 2006-06-16 | ヒトおよび愛玩動物のための抗白癬入浴剤 |
Country Status (1)
Country | Link |
---|---|
JP (1) | JP2007332126A (ja) |
Cited By (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP2016513650A (ja) * | 2013-03-13 | 2016-05-16 | ビロクシス コーポレイション | 白檀油を含む安定化クリーム製剤 |
US20160346177A1 (en) * | 2014-02-06 | 2016-12-01 | Robertet S.A. | New use of parfumery compounds against hair regrowth |
Citations (8)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPS5432636A (en) * | 1977-08-12 | 1979-03-10 | Toyota Matsunaga | Bathing agent composition for treating skin desease |
JP2000119188A (ja) * | 1997-03-26 | 2000-04-25 | Meril Skyers | ヒト免疫不全ウイルスおよびその他感染性疾患の抗菌予防と治療 |
JP2000309524A (ja) * | 1999-02-22 | 2000-11-07 | Kao Corp | 浴用剤組成物 |
JP2003192581A (ja) * | 2001-12-26 | 2003-07-09 | Lion Corp | 抗菌組成物 |
JP2005255640A (ja) * | 2004-03-12 | 2005-09-22 | Nature Technology Inc | 球状粒子及びその製造方法 |
JP2005533767A (ja) * | 2002-05-24 | 2005-11-10 | トゥリスファルマ ソシエタ ア レスポンサビリタ リミタータ | テルペン基材組成物、その調製方法および大気散布方法 |
JP2006034914A (ja) * | 2004-07-23 | 2006-02-09 | Shigeru Abe | 白癬の温熱治療法および治療具 |
JP2006124296A (ja) * | 2004-10-27 | 2006-05-18 | Tomihiko Higuchi | ヘリコバクター・ピロリ菌感染症治療のための医薬組成物 |
-
2006
- 2006-06-16 JP JP2006193389A patent/JP2007332126A/ja active Pending
Patent Citations (8)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPS5432636A (en) * | 1977-08-12 | 1979-03-10 | Toyota Matsunaga | Bathing agent composition for treating skin desease |
JP2000119188A (ja) * | 1997-03-26 | 2000-04-25 | Meril Skyers | ヒト免疫不全ウイルスおよびその他感染性疾患の抗菌予防と治療 |
JP2000309524A (ja) * | 1999-02-22 | 2000-11-07 | Kao Corp | 浴用剤組成物 |
JP2003192581A (ja) * | 2001-12-26 | 2003-07-09 | Lion Corp | 抗菌組成物 |
JP2005533767A (ja) * | 2002-05-24 | 2005-11-10 | トゥリスファルマ ソシエタ ア レスポンサビリタ リミタータ | テルペン基材組成物、その調製方法および大気散布方法 |
JP2005255640A (ja) * | 2004-03-12 | 2005-09-22 | Nature Technology Inc | 球状粒子及びその製造方法 |
JP2006034914A (ja) * | 2004-07-23 | 2006-02-09 | Shigeru Abe | 白癬の温熱治療法および治療具 |
JP2006124296A (ja) * | 2004-10-27 | 2006-05-18 | Tomihiko Higuchi | ヘリコバクター・ピロリ菌感染症治療のための医薬組成物 |
Cited By (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP2016513650A (ja) * | 2013-03-13 | 2016-05-16 | ビロクシス コーポレイション | 白檀油を含む安定化クリーム製剤 |
US20160346177A1 (en) * | 2014-02-06 | 2016-12-01 | Robertet S.A. | New use of parfumery compounds against hair regrowth |
US9801796B2 (en) * | 2014-02-06 | 2017-10-31 | Robertet S.A. | Use of parfumery compounds against hair regrowth |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
Mullai et al. | Bactericidal activity of different types of honey against clinical and environmental isolates of Pseudomonas aeruginosa | |
Lin et al. | Interactions between Candida albicans and Staphylococcus aureus within mixed species biofilms | |
AU2004287281A1 (en) | Disinfecting composition and methods of making and using same | |
JP5820194B2 (ja) | 新たな抗カンジダ活性組成物 | |
US20190269634A1 (en) | Volatile Organic Compound Formulations Having Antimicrobial Activity | |
CN107735083B (zh) | 抗菌组合物 | |
CN101590287A (zh) | 伤口填料 | |
CN104672293A (zh) | 一种五环三萜结构修饰化合物及其制备方法和应用 | |
US6846847B2 (en) | Biocidal agents and methods of use | |
JP2007332126A (ja) | ヒトおよび愛玩動物のための抗白癬入浴剤 | |
CN1251738C (zh) | 一种治疗灰指甲的中药及其制备方法 | |
US20130337095A1 (en) | Antimicrobial composition and its method of use | |
JP2019178170A (ja) | 抗微生物作用を備えた組成物の製造のためのパチョリ抽出物の使用 | |
RU2613708C2 (ru) | Способ лечения угревой болезни | |
CN101077362A (zh) | 植物型皮肤黏膜消毒剂 | |
Agbagwa et al. | Antibacterial Efficacy and Healing Potential of Honey from Different Zones in Nigeria on Diabetic‐Induced Wound Infection in Wistar Rats | |
US20050165104A1 (en) | Biocidal agents and veterinary methods | |
CA3117821A1 (en) | Volatile organic compound formulations having antimicrobial activity | |
CN1095377C (zh) | 治疗皮肤癣症、炎症的药物及其制备方法 | |
Haidari et al. | Antibacterial hydrogel therapy for eradication of wound associated polymicrobial biofilms | |
RU2391821C2 (ru) | Терапевтическое средство "фузобаквелт" на основе наносомной субстанции | |
RU2316330C2 (ru) | Препарат для лечения микозов и гнойной инфекции | |
US10398664B2 (en) | Methods of diagnosing and treating infected implants | |
JP2010510200A (ja) | ブドウ球菌感染症の治療のためのクロトリマゾール | |
Agbagwa et al. | Research Article Antibacterial Efficacy and Healing Potential of Honey from Different Zones in Nigeria on Diabetic-Induced Wound Infection in Wistar Rats |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
A621 | Written request for application examination |
Free format text: JAPANESE INTERMEDIATE CODE: A621 Effective date: 20081203 |
|
A977 | Report on retrieval |
Free format text: JAPANESE INTERMEDIATE CODE: A971007 Effective date: 20110127 |
|
A131 | Notification of reasons for refusal |
Free format text: JAPANESE INTERMEDIATE CODE: A131 Effective date: 20110816 |
|
A521 | Written amendment |
Free format text: JAPANESE INTERMEDIATE CODE: A523 Effective date: 20111013 |
|
A131 | Notification of reasons for refusal |
Free format text: JAPANESE INTERMEDIATE CODE: A131 Effective date: 20120327 |
|
A02 | Decision of refusal |
Free format text: JAPANESE INTERMEDIATE CODE: A02 Effective date: 20130129 |